Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
LC|n 2020182515
(VIAF cluster)
(Authority/Source Record)
|
005
|
|
|
20200331054415.0 |
008
|
|
|
200330n| azannaabn |a aaa |
003
|
|
|
LC |
035
|
|
|
‡a
(LC)11326448
|
010
|
|
|
‡a
n 2020182515
|
035
|
|
|
‡a
(DNLM)1852023
|
035
|
|
|
‡a
(DLC)11328584
|
035
|
|
|
‡a
(DLC)n 2020182515
|
040
|
|
|
‡a
DNLM
‡b
eng
‡e
rda
‡c
DNLM
|
100
|
1 |
|
‡a
Astudillo-de la Vega, Horacio
|
370
|
|
|
‡f
Mexico City (Mexico)
‡2
naf
|
372
|
|
|
‡a
Medical Oncology
‡2
mesh
|
373
|
|
|
‡a
Hospital de Oncologia (Mexico City, Mexico)
‡2
naf
|
400
|
1 |
|
‡a
De la Vega, Horacio Astudillo-
|
400
|
1 |
|
‡a
La Vega, Horacio Astudillo-de
|
400
|
1 |
|
‡a
Vega, Horacio Astudillo-de la
|
670
|
|
|
‡a
Translational research and onco-omics applications in the era of cancer personal genomics, 2019:
‡b
title page (Horacio Astudillo-de la Vega) t.p. verso (Translational Research Laboratory in Cancer & Celullar Therapy, Hospital de Oncologia, Siglo XXI, IMSS, Mexico City, Mexico)
|
919
|
|
|
‡a
translationalresearchandoncoomicsapplicationsintheeraofcancerpersonalgenomics
‡A
Translational research and onco-omics applications in the era of cancer personal genomics, 2019:
‡9
1
|
943
|
|
|
‡a
201x
‡A
2019
‡9
1
|
970
|
|
|
‡a
medical oncology
‡A
Medical Oncology
‡9
1
|
996
|
|
|
‡2
WKP|Q30331452
|
996
|
|
|
‡2
J9U|987012502372505171
|
996
|
|
|
‡2
DNB|1057176680
|
996
|
|
|
‡2
WKP|Q3786752
|
996
|
|
|
‡2
ISNI|0000000496685541
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Astudillo-de la Vega, Horacio
‡2
J9U|987012502372505171
‡3
viafid
‡3
lccn:n2020-182515
|